Potential risk factors for medication non-adherence in patients with chronic obstructive pulmonary disease (COPD). - Wikidata - wikimedia - TriplyDB

Potential risk factors for medication non-adherence in patients with chronic obstructive pulmonary disease (COPD).

Potential risk factors for medication non-adherence in patients with chronic obstructive pulmonary disease (COPD).

http://www.wikidata.org/entity/Q38000037

about

Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease What else should we know about experiencing COPD? A narrative review in search of patients' psychological burden alleviation Health screening behaviors among adults with hereditary hemorrhagic telangiectasia in North America Efficacy of a multifactorial intervention on therapeutic adherence in patients with chronic obstructive pulmonary disease (COPD): a randomized controlled trial.Low use and adherence to maintenance medication in chronic obstructive pulmonary disease in the general population.Chronic Obstructive Pulmonary Disease Illness and Medication Beliefs are Associated with Medication Adherence Awareness of COPD in a high risk Korean population.Extent and reasons for nonadherence to antihypertensive, cholesterol, and diabetes medications: the association with depressive symptom burden in a sample of American veterans.Awareness of chronic obstructive pulmonary disease in current smokers: a nationwide survey.Impact of multiple-dose versus single-dose inhaler devices on COPD patients' persistence with long-acting β₂-agonists: a dispensing database analysis The Association of Health Literacy with Illness and Medication Beliefs among Patients with Chronic Obstructive Pulmonary Disease Changing factors associated with parent activation after pediatric hematopoietic stem cell transplant.Improving outcomes in chronic obstructive pulmonary disease: the role of the interprofessional approach.Health behaviors and their correlates among participants in the Continuing to Confront COPD International Patient Survey.Rheumatologist and Primary Care Management of Cardiovascular Disease Risk in Rheumatoid Arthritis: Patient and Provider Perspectives.Therapeutic paralysis in veterans with COPD.Association between depression and maintenance medication adherence among Medicare beneficiaries with chronic obstructive pulmonary disease.Intentional non-adherence to medications by older adults.Patient-reported outcomes and considerations in the management of COPD: focus on aclidinium.Suboptimal inhaler medication adherence and incorrect technique are common among chronic obstructive pulmonary disease patients.Association between Social Support and Self-Care Behaviors in Adults with Chronic Obstructive Pulmonary Disease.Quality of life and adherence to inhaled corticosteroids and tiotropium in COPD are related.Adherence to Maintenance Medications among Older Adults with Chronic Obstructive Pulmonary Disease. The Role of Depression.Psychometric Properties of the COPD-Specific Beliefs About Medicine Questionnaire in an Outpatient Population: A Rasch-Analysis.Systems Medicine: from molecular features and models to the clinic in COPD.Psychosocial Predictors of HBV Screening Behavior among Vietnamese Americans.Is patient empowerment the key to promote adherence? A systematic review of the relationship between self-efficacy, health locus of control and medication adherence.Association between refill compliance to oral bisphosphonate treatment, incident fractures, and health care costs--an analysis using national health databases.Association of comorbid anxiety and depression with chronic obstructive pulmonary disease.Frequent Exacerbator: The Phenotype at Risk of Depressive Symptoms in Geriatric COPD Patients.Pattern and Adherence to Maintenance Medication Use in Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease: 2008-2013.Does hospitalization influence patients' medication adherence and community pharmacists' interventions?Adherence to COPD treatment in Turkey and Saudi Arabia: results of the ADCARE study.Real-world outcomes in patients with chronic obstructive pulmonary disease initiating long-acting mono bronchodilator therapy.Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD)

P2860

Q27000043-2826712C-740E-470E-BBD0-0A03A6E4F8C2 Q28066555-AACE364F-0F8D-45D5-A42B-68DD1BD53D43 Q33563773-3BB50121-BCAA-4312-9E49-15B3CC87B658 Q33573085-6BA843DE-767B-4270-AEA1-250F343A2CA8 Q34826231-F915612D-4630-4CE2-B597-DD5D21059489 Q35008081-70E3EEDD-D285-4095-A38E-D7483C5CE36C Q35086039-8253454C-4626-479A-885E-BE43305812BB Q35136139-21E704E6-C233-4CA8-8D7D-F9380289BBEA Q35152641-01638B1F-DCCA-4B46-8876-67216E81BDD7 Q35216376-85988C02-177F-4010-A4F9-E42E89DBCC5E Q35542469-EA55AEEE-9CAC-470F-846B-BF6C28ABA0CB Q35667530-26B01561-1320-41F6-AD30-13E87E122337 Q35821928-1F83C7D5-ADC3-4044-BDBF-96D706993CF0 Q36858219-D4E49EF5-86EB-4A28-A45D-2926ED858D19 Q36970912-F937A624-51E4-4DB9-B514-7C7F98DB6243 Q37198731-5A32D502-DB7D-4DBC-B983-038EBD64C271 Q37230812-4B8C8E33-6600-4AD6-95CA-AC6A1C933860 Q38190869-EA02EE86-4A42-4D7F-AB07-0D7A6281DCC0 Q38344780-172F6F57-EE39-4D07-965D-08E0D8E6A0D3 Q38442023-6A380125-5160-4FF7-A36C-CFE18B19F404 Q38673976-47642777-C43F-4EB7-8DCB-7722E350B1E1 Q39459241-5E6FA378-77D6-40EC-B2D2-C1D92BAFAEF5 Q39663376-9553CC07-F55C-4959-994A-E6E1092CF78E Q41402281-9816456E-F355-4A5C-8921-C16A85D09B2F Q41731469-E545728A-5AFD-42D7-9ADF-18E8A894A418 Q42032765-A881DBA2-838E-48D0-B22F-03E2FB98FC88 Q42685293-9F495D73-4D43-4D31-9766-D960726C8406 Q43573067-3FDDF721-16E3-49F1-96C7-9603C25769B4 Q47659647-82D3E3C8-B2FF-4CD8-B986-4FD15735E32E Q48056475-F6DD15EE-4D5F-4454-B6B4-6EF8C1D9E5F5 Q52599392-E9695F80-8E73-4E35-8C97-F63E21ED65E6 Q54561788-A028F311-9DED-48F1-9E2B-E2201F81C3E7 Q55228694-1F0C8C27-8B51-44CB-B849-DBA71AEC7995 Q55451529-72148860-60CB-4B4E-AD24-01DF35F2C135 Q57809552-C8AFC6C7-CDFA-44B7-BF27-5CC7AD3F61DA

P2860

Potential risk factors for medication non-adherence in patients with chronic obstructive pulmonary disease (COPD).

http://www.wikidata.org/entity/Q38000037

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Potential risk factors for med ...... tive pulmonary disease (COPD).

@en

type

label

Potential risk factors for med ...... tive pulmonary disease (COPD).

@en

prefLabel

Potential risk factors for med ...... tive pulmonary disease (COPD).

@en

P1433

Q38000037-77FC4061-7DD2-452A-B249-BD5D9CCE2547

P1476

Q38000037-21209029-B68D-4260-8F91-CA76FB7A8BC7

P2093

Q38000037-732938B4-224C-4CD2-ACC2-3ECBC9DFAC6F

Q38000037-8999F3DF-71A1-46A5-9CA9-0F76642E09B8

Q38000037-99B2BEB0-6AF3-4CD6-87E9-0A0B84DA26CB

P2860

Q38000037-00BF1921-61D1-40FE-BEFC-B073878FC1D6

Q38000037-01B3FEFB-9C95-45B7-8D1C-61BF859D5D38

Q38000037-04EDD3B5-FC6D-418B-ABBF-C407CBDC1F1D

Q38000037-125E4E15-9749-4C22-A939-AC5D22BBF8EB

Q38000037-254DAE36-22F3-4FAA-B00A-31894D397BD7

Q38000037-2F8F924F-C18D-4099-8AD0-86C8D8134C83

Q38000037-350FB5AA-3009-430B-8360-31C01B927CEB

Q38000037-354509DF-B3D2-48BC-AFC5-EB2DC3C48780

Q38000037-360CBFB8-E122-42B2-AF82-2929DF3F7C6C

Q38000037-41EBE1D1-495A-45D6-9CD6-1938BED1276E

P2888

Q38000037-E452AA11-06F9-459A-AA0E-F70A8768F9D4

P304

Q38000037-3172F282-FAA7-425A-BB10-2875432B2CE8

P31

Q38000037-5F06A6DB-0EB1-4DE0-BC4D-7B555995E953

P356

Q38000037-B2EE9C0F-16C7-4D8D-98B7-070073079814

P433

Q38000037-D6F8F748-9333-40E5-9EB9-EAA2FF9A5129

P478

Q38000037-E41B51C7-E2E3-4D70-9E29-F0557B08D995

P50

Q38000037-4E5F04F6-2247-41FE-9B74-615ADFD73F33

Q38000037-6183B60E-4CD3-413B-BA03-3BF87E9C3DFB

P577

Q38000037-BAAE64EB-98C2-4B56-9889-147379BE7D35

P5875

Q38000037-2EDC4227-7BC9-43BB-A222-1DFC3657858D

P6179

Q38000037-F6D71F78-A2CD-4267-A796-4F34C33CD1F4

P698

Q38000037-5E6C05F4-419C-4108-AC4D-023713023550

P921

Q38000037-BCDE6980-132F-4128-96D9-54F67805EA86

P356

S00228-012-1279-5

P1433

European Journal of Clinical Pharmacology

P1476

Potential risk factors for med ...... ctive pulmonary disease (COPD)

@en

P2093

Bronagh M Smyth

http://www.w3.org/2001/XMLSchema#string

James C McElnay

http://www.w3.org/2001/XMLSchema#string

Joseph C Kidney

http://www.w3.org/2001/XMLSchema#string

P2860

The hospital anxiety and depression scale

Self-efficacy: toward a unifying theory of behavioral change

Adherence to Medication

Developing a structured education programme for clients with COPD.

Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence.

The validity of the Hospital Anxiety and Depression Scale. An updated literature review.

Patients' decisions about whether or not to take antihypertensive drugs: qualitative study.

Knowledge, attitudes, and self-efficacy and compliance with medical regimen, number of emergency department visits, and hospitalizations in adults with asthma.

Explaining adherence to supplemental oxygen therapy: the patient's perspective.

Clinical pharmacy-led disease and medicine management programme for patients with COPD.

P2888

s00228-012-1279-5

P304

1365-1373

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00228-012-1279-5

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

223958252

http://www.w3.org/2001/XMLSchema#string

P6179

1047454295

http://www.w3.org/2001/XMLSchema#string

P698

22476392

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease